Pharmacokinetics Flashcards

1
Q

Study of the mechanisms and quantitative characteristics of drug liberation, drug absorption, distribution, metabolism/biotransformation, and excretion (ADME)

A

Pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

4 aspects studied by pharmacokinetics

A

Drug absorption, distribution, metabolism/biotransformation, and excretion (ADME)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

passage of drug between site of administration and vascular compartment

A

Absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Enteral routes of administration (4)

A

Oral, buccal, sublingual, rectal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 Non-alimentary routes of administration

A

Pulmonary/inhalation, Parenteral (IV, intraperitoneal, intra-arterial, intraspinal, subcutaneous, intramuscular), topical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Many quick dissolve drugs are not actually sublingual or buccal forms, but simply this

A

Drug delivery systems that quickly dissolve in the moisture of the mouth
Dissolved drug must be swallowed for absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sublingual and buccal routes of administration are limited to drugs that are _____ soluble and taste good

A

Lipid soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 factors that affect GI function and can affect oral drug absorption

A

Drug characteristics
Transit time
Absorptive surface area
Food may interfere with dissolution and absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Can you split extended release tablets/capsules/pills?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Route of administration that is Usable in unconscious patient, vomiting patient, and in infants
Compliance is major problem
Good absorptive profile
NO first pass effect

A

Rectal route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Is there first pass effect with rectal route of administration?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

To be absorbed in the stomach, a drug must be ______

A

Acidic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Basic drugs likely get absorbed here

A

In the intestine
If they survive the acidic environment of the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Occurs when portal blood delivers a drug to the liver
The liver biotransforms the drug before it reaches systemic circulation
OR Liver extracts the drug into the bile before it reaches systemic circulation
Net effect: the amount of unchanged drug entering systemic circulation is reduced
May represent a loss of bioavailability

A

First Pass Effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the net effect of the First Pass Effect

A

The amount of unchanged drug entering systemic circulation is reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The first pass effect occurs because of this

A

Portal blood delivers drug to liver where it is biotransformed or extracted into the bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Oral nitroglycerin is subject to this

A

First pass effect
Use sublingual route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Oral drug that is subject to first pass effect and uses sublingual route

A

Nitroglycerin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Primary area of absorption for oral route

A

Small intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Organ with large absorptive surface area
Possible first pass effect

A

Small intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Does the first pass effect occur with the small intestine?

A

Possible yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Most absorption in the small intestine occurs here

A

In first 2 meters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Small intestine is primary area of absorption for this route

A

Oral route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Organ with limited role in drug absorption; small absorptive surface area, long ‘contact’ time
Dense contents limits access to absorptive surface

A

Large intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
The inhalation route has good absorptive capacity here
In alveolar spaces
26
Route that is closest to ideal for diffusion High surface area; highly permeable membranes Many drugs do not reach this space, are not absorbed; Requires gas, aerosol or fine particle
Inhalation route
27
3 common adverse effects of the inhalation route
Cough, irritation of throat, bronchospasm
28
What type of drugs are inhalers for asthma and COPD?
Topical drugs (not inhaled drugs) Only deliver drug to the upper airway structures without necessary entry into blood
29
Route of administration where systemic absorption is normally minimal Drug must be non-irritating Compliance depends on physical characteristics of drug or vehicle
Topical route
30
Systemic absorption with the topical route is increased with these 4 factors
Increased lipid solubility Conditions associated with enhanced skin permeability Application to large surface area High dosages
31
Route of administration that uses patch medications Highly lipophilic drugs only Generally used for short acting drugs Slow onset of effect may be a limiting feature
Transdermal delivery
32
Transdermal deliver requires this type of drugs only
Highly lipophilic drugs only
33
Patch medications use this type of delivery
Transdermal
34
Route of administration involving proteins absorbed via lymph Vehicle, volume, surface area, site of administration, environmental factors all contribute to absorption Implants or suspensions can be used
Subcutaneous or intramuscular routes
35
Drugs given via the subcutaneous or intramuscular routes are absorbed via this
Lymph
36
Route of administration where sterile techniques and materials are obligatory Rate of administration is important variable Irreversible as drug is automatically in blood (so not real absorption) Drug must be water soluble or micro-suspension Only routes guaranteed to provide 100% bioavailability
Intravenous or intra-arterial routes
37
Only routes of administration guaranteed to provide 100% bioavailability
Intravenous or intra-arterial routes
38
Routes of administration where there is no absorption since drug is directly applied to the vascular space
Intravenous or intra-arterial routes
39
Routes of administration that are irreversible as drug is automatically in blood
Intravenous or intra-arterial routes
40
Intravenous or intra-arterial routes requires drugs that are this
Water soluble or micro-suspension
41
Does the first pass effect occur with the intraperitoneal route?
Yes
42
Route that is similar to oral without the problems associated with the stomach or intestine First pass effect
Intraperitoneal
43
Route of administration where Drug is placed inside meninges Requires high degree of training and skill Little margin for error permitted Ensues access to CNS with all inherent risks NOT the same as an epidural
Intrathecal route
44
Drugs given via the intrathecal route are placed here
Inside meninges
45
4 drug characteristics that favor crossing membranes
Uncharged Nonpolar Low molecular weight High lipid solubility
46
Drug permeation process that is not saturable; most drugs use this to move along concentration gradient Paracellular transport Diffusion is most important limiting factor
Passive
47
Drug permeation process that is saturable, can be facilitated or active transport (moves substance against gradient)
Special carriers
48
Drug permeation process that used for proteins and very large molecules
Endocytosis/exocytosis
49
Number used to predict the membrane permeability of a drug at different pH values
Negative log of a drug's dissociation constant (pKa)
50
Henderson-Hasselbalch can be used to predict this
How much drug crosses membrane
51
Used to predict the portion of a drug that will permeate a membrane in a given pH environment based on the drug pKa
Henderson-Hasselbalch
52
Degree of ionization for weak acids are greater at ______ pH
Higher
53
Degree of ionization for weak acids are lesser at ______ pH
Lower
54
Degree of ionization for weak bases are greater at ______ pH
Lower
55
Degree of ionization for weak bases are lesser at ______ pH
Higher
56
Is the pKa for a drug constant?
Yes
57
Will a weak acid be ionized when solvent pH is less than its pKa?
Unionized (acid - acid)
58
Will a weak acid be ionized when solvent pH is more than its pKa?
Ionized (base - acid)
59
Will a weak base be ionized when solvent pH is less than its pKa?
Ionized (acid - base)
60
Will a weak base be ionized when solvent pH is more than its pKa?
Unionized (base - base)
61
If pH < pKa, solvent is _____ relative to drug
Acidic
62
If pH > pKa, solvent is _____ relative to drug
Basic
63
Weak acids are ionized in ______ solvents
Basic
64
Weak acids are unionized in ______ solvents
Acid
65
Weak bases are ionized in ______ solvents
Acidic
66
Weak bases are unionized in ______ solvents
Basic
67
10 ^ ([pH - pKa]) predicts this
Ratio of drug ionized to unionized
68
ATP-driven efflux transporter expressed in intestine and other tissues 'Pumps’ drugs back into the intestinal lumen or out of cells and into blood Substrates include anti-cancer drugs, immunosuppressive drugs and some drugs used to treat heart failure Reduces absorption
P-glycoprotein (Pgp)
69
P-glycoprotein does this
Pumps drugs back into intestinal lumen or out of cells and into blood Reduces absorption
70
P-glycoprotein expression is increased by this
TB antibiotic rifampicin Leads to reduced drug absorption
71
TB antibiotic rifampicin has this affect on P-glycoprotein
Induces expression, leads to reduced drug absorption
72
TB antibiotic rifampicin has this affect on drug absorption
Reduces due to increased expression of P-glycoprotein
73
P-glycoprotein is inhibited by this drug, thus increasing drug absorption
Verapamil
74
Fraction of total drug administered that is transferred to blood (how much drug eventually gets into circulation)
Bioavailability (F)
75
Bioavailability (F) of IV route
100%
76
Oral route has bioavailability F<100% due to this
First pass metabolism by liver and incomplete absorption into systemic blood
77
Effect that removes drug before systemic circulation
First pass metabolism
78
This can be reduced by formation of insoluble complexes in GI
Bioavailability
79
Equation to convert dosage when changing drug formulation
Dose1 x F1 = Dose2 x F2
80
How many nanograms in a microgram?
1 ug = 1000 ng
81
Blood flow to a tissue/region determines the rate of drug delivery and can contribute to termination of drug action
Distribution
82
Key concept of distribution A mathematically definable space to which drug may enter and exit
Compartments
83
3 possible compartments involved in drug distribution
Plasma, interstitial fluid, and cells
84
Changes in this compartment will be directly reflective of changes in connected areas
Plasma
85
Describe the one compartment model of distribution
Plasma is in equilibrium with interstitial areas and is accessible Changes in plasma will be directly reflective of changes in connected areas Plasma is surrogate for other compartments
86
Equation for volume; used to understand drug distribution throughout a compartment
Volume = Dose / Plasma Concentration
87
hypothetical volume in which a dose (D) of drug would have to be placed in to obtain the measured plasma concentration (Cp)
Volume of distribution (Vd) Vd = D / Plasma concentration = (mg/kg) / (mg/L) = L/kg
88
Vd of 3-5 indicates a drug is likely distributed in this
Plasma water
89
Vd of 5-10 indicates a drug is likely distributed in this
Blood volume
90
Vd of 10-20 indicates a drug is likely distributed in this
Interstitial space
91
Vd of 22-42 indicates a drug is likely distributed in this
Total body water
92
Vd of >70 indicates a drug is likely distributed in this
Tissue bound (or even accumulating)
93
Vd is inversely related to this
Drug concentration for a given dose
94
Large Vd are associated with low drug plasma concentration and imply high ______ solubility
High lipid solubility (low water solubility)
95
Small Vd are associated with high drug plasma concentration and imply high ______ solubility
High water solubility (low lipid solubility)
96
Does large or small Vd have longer durations of action?
Large
97
Does large or small Vd have shorter durations of action?
Small
98
Does large Vd indicate long or short durations of action?
Long
99
Does small Vd indicate long or short durations of action?
Short
100
Describes how much drug must be given at one time to achieve effective blood levels Used to achieve a desired blood level (concentration at steady state) quickly and reliably
Loading dose = Vd x TC/F TC = target concentration
101
Equation for loading dose
Loading dose = Vd x TC/F (TC = target concentation; F = bioavailability)
102
What is loading dose used for?
Used to achieve a desired blood level (concentration at steady state) quickly and reliably
103
Only _____ drug is active drug
Free drug
104
Protein binding typically parallels increased _______
Lipid solubility
105
This typically parallels increased lipid solubility
Protein binding
106
Are drugs with large or small Vd often highly protein bound?
Large
107
Most common acceptor protein in the body; 50% serum protein
Albumin
108
Common acceptor protein binding cardiovascular and centrally acting drugs
Alpha1-acid glycoprotein
109
3 drug acceptor proteins
Albumin Lipoprotein Alpha1-acid glycoprotein
110
Process of enzymatic biotransformation of a drug into another compound (a metabolite) Generally regarded as a function of the liver, though GI tract, kidney and placenta have capacity Usually results in drug conversion to a more polar form more likely to be renally excreted Not always an inactivation process, as the metabolite may be the active form of the drug.
Metabolism/biotransformation
111
Metabolism usually results in drug conversion to a more ______ form that is more likely to be renally excreted
Polar
112
Type of drugs that have little or no activity until biotransformed
Prodrugs
113
Two primary biotransformation pathways
Phase I reactions (oxidation, reduction, hydrolysis) Phase II reactions (conjugation, acetylation, methylation)
114
3 types of reactions involved in phase I reactions of biotransformation
Oxidation, reduction, hydrolysis
115
3 types of reactions involved in phase II reactions of biotransformation
Conjugation, acetylation, methylation
116
Most common phase I reaction
Oxidation
117
Most important oxidation system of phase I reactions of biotransformation
Cytochrome P450 oxidative system (CYP, mixed function oxidase (MFO), monooxygenase, microsomal enzyme system)
118
Phase I or II reactions of biotransformation: Destructive pathways as primary compound is forever changed Often diminished in elderly patients
Phase I
119
Cytochrome P450 oxidative system is involved in Phase I or II reactions of biotransformation?
Phase I
120
Are these reactions Phase I or II of biotransformation: Oxidation, reduction, hydrolysis
Phase I
121
Are these reactions Phase I or II of biotransformation: Conjugation, acetylation, methylation
Phase II
122
Intracellular location of cytochrome P450 oxidative system
Endoplasmic reticulum
123
Predominant CYP isoform; amount and importance, accounts for a lot of first pass effect High interaction potential Few genetic polymorphisms
CYP 3A4/5
124
CYP 3A4/5 is induced by
Smoke and some vegetables
125
CYP 3A4/5 is inhibited by
Some antibiotics (quinolone and macrolides) and grapefruit
126
Partial irreversible inhibitor of CYP 3A4
Grapefruit
127
CYP 3A4/5 is especially important for these drugs
Orally administered drugs biotransformed by intestinal wall CYP3A4 enzymes E.g. lovastatin (Mevacor)
128
Recovery half-life of CYP 3A4/5
About one day
129
Does CYP 3A4/5 have genetic polymorphisms?
No; few
130
Grapefruit is a partial irreversible inhibitor of this
CYP 3A4
131
CYP that is especially important for orally administered drugs biotransformed by intestinal wall E.g. lovastain (Mevacor)
CYP 3A4
132
CYP with high interaction potential Induced by many drugs (anticonvulsants, warfarin) Clinically important genetic polymorphisms have different metabolizing capacity than more common genotypes (some are poor metabolizers, reducing first pass metabolism and patient exposure to drugs)
CYP 2C8/9/10
133
Drugs that induce CYP 2C8/9/10
Anticonvulsants and warfarin
134
Does CYP 2C8/9/10 have genetic polymorphisms?
Yes! Clinically important genetic polymorphisms in CYP2C9 and CYP2C19 have different metabolizing capacity than more common genotypes Some are poor metabolizers, reducing first pass metabolism and patient exposure to drugs
135
Does CYP 3A4/5 have high or low interaction potential?
High
136
Does CYP 2C8/9/10 have high or low interaction potential?
High
137
Second most predominant CYP isoform Highest number of genetic polymorphisms Deficiencies are common; hyper metabolizers are noted Several inhibitors noted including many cardiovascular and psychoactive drugs
CYP 2D6
138
Does CYP 2D6 have genetic polymorphisms?
Yes! Highest number of genetic polymorphisms 7% Caucasians are deficient 1-3% African Americans and Asians are deficient Hyper metabolizers (multiple copies of CYP 2D6 gene) are noted
139
Percentage of caucasians that are deficient in CYP 2D6
7%
140
Percentage of African Americans and Asians are deficient in CYP 2D6
1-3%
141
30% of cytochrome P450 interactions involve this CYP
CYP 2D6
142
Hyper metabolizers (multiple copies of the CYP gene) are noted for this CYP
CYP 2D6
143
Inhibitors of CYP 2D6
Cardiovascular and pyschoactive drugs
144
Drugs that inhibit CYP450 activity are often this mechanism-based
Covalent "suicide" inhibitors
145
5 drugs that induce CYP expression
Anticonvulsants Rifampin (anti TB) Chronic alcohol Glucocorticoids Phenobarbital
146
Induction of CYP involves increased this
Heme protein synthesis
147
Induction of an increase in CYP450 expression results from this
Elevated CYP450 mRNA production
148
Deficiency of heme synthesis pathways and during CYP induction toxic levels of heme proteins may accumulate
Porphyria
149
Porphyria is this
Deficiency of heme synthesis pathways During CYP induction toxic levels of heme proteins may accumulate
150
Phase I or II reactions of biotransformation: Synthetic pathways as primary compound is chemically added; attaches a polar group to the drug by transferase enzymes Final result generally very polar compared to parent compound, more likely to make product excretable (renally or in bile) than phase 1 process
Phase II
151
Final result of phase II reactions is generally ________ compared to parent compound, and more likely to be excreted (renal or bile) than phase I process
Very polar
152
Kidneys can’t easily eliminate _________ drugs, so these drugs need to be made more hydrophilic by phase I and II reactions
Lipophilic (membrane permeable)
153
Is conjugated drug usually active or inactive?
Inactive
154
Following Phase I reactions, drug is most often _______
Inactivated
155
6 factors that affect drug biotransformation
Enzyme induction Genetics Age Nutrition Disease (hepatitis, cirrhosis) Other drugs
156
Does increased activity or cytochrome P450 system enhance or reduce metabolism of substrates?
Enhance Drugs removed faster, inadequate dose, subtherapeutic levels
157
Levels of drug biotransformation in newborn
Limited
158
Levels of drug biotransformation in adolescence
Unstable and often high
159
Levels of drug biotransformation in puberty
Relatively high
160
Levels of drug biotransformation in great age
Diminished
161
Nutrition reduces biotransformation in these 3 conditions
Protein deficiency Diets deficient in essential fatty acids Excessive intake of glucose, sucrose, or fructose
162
2 diseases that affect drug biotransformation
Hepatitis, cirrhosis
163
Two primary mechanisms for clearing drugs and their metabolites from the body:
Hepatic and biliary clearance Renal clearance
164
Renal drug clearance mechanisms are the same as for endogenous substances and include these 3 mechanisms:
Glomerular filtration Tubular secretion (active process) Tubular reabsorption (may be active or passive, mostly passive diffusion)
165
Is tubular secretion an active or passive process?
Active
166
Is tubular reabsorption an active or passive process?
May be active or passive Mostly passive diffusion
167
Only a small fraction of drug is cleared by this in each pass through the kidneys
Glomerular filtration
168
Drugs bound to plasma protein are too large to be cleared by this
Glomerular filtration
169
Route of elimination that is available to volatiles, diffusion is primary mechanisms Have relatively high level of biotransformation potential
Pulmonary elimination
170
Many drugs are subject to a pulmonary "first pass" effect because of this
Lungs have a relatively high level of biotransformation potential
171
Following process such as conjugation with __________, a drug is excreted by the liver cells into the bile and then delivered to the small intestine
Glucuronic acid
172
Type of excretion important for some molecules that are anionic, cationic, or non-ionized molecules containing polar or lipophilic groups
Biliary excretion
173
When deciding on starting doses for a drug eliminated by renal processes, the patient’s renal function should be assessed by this level
Creatinine clearance (CrCl)
174
Normal creatinine clearance (CrCl) range
70-160 mg/min
175
Creatinine clearance (CrCl) range that indicates a minor dosage adjustment is needed
30-60 mg/min
176
Creatinine clearance (CrCl) range that indicates moderate dosage adjustment is needed
15-30 mg/min
177
Creatinine clearance (CrCl) range that indicates a major dosage adjustment is needed
Below 15 mg/min
178
_________ has an impact on the magnitude and duration of responses to drugs
Pharmacokinetics
179
Equation for clearance
Cl = rate of drug elimination / plasma drug concentration
180
Is clearance specific for route of elimination?
NO If multiple routes of elimination exist, the clearance rate is additive
181
Time required for drug serum concentration to decline by one half after absorption and distribution are complete
Half life (T 1/2)
182
Do rapidly eliminated drugs (large clearance values) have short or long half lives?
Short
183
Do slowly eliminated drugs (small clearance values) have short or long half lives?
Long
184
Equation for half life
T 1/2 = 0.7 / Ke (Ke = elimination constant for that drug)
185
Relation between clearance and half life
Clearance is inversely related to half life
186
Two primary mathematical models of elimination
Zero (aka linear) and first (aka nonlinear) order kinetics
187
Mathematical modeling of elimination: Amount per unit time Rate is constant and independent of drug Typical of biological processes that are saturated Unusual Dependent on starting drug concentration Half-life is not constant, but each subsequent half-life is half of the preceding one
Zero order kinetics (aka linear or saturation kinetics)
188
Mathematical modeling of elimination: Fractions per unit time Rate is diminishing and always in proportion to the amount of drug in the body Typical Half-life is constant regardless of drug concentration
First order kinetics (aka nonlinear kinetics)
189
Mathematical modeling of elimination: Amount per unit time
Zero order kinetics
190
Mathematical modeling of elimination: Fractions per unit time
First order kinetics
191
First order kinetics are linearized when using this
Semi-log Y-axis
192
Mathematical modeling of elimination: Half-life is dependent on starting drug concentration
Zero order kinetics
193
Mathematical modeling of elimination: Half-life is constant regardless of drug concentration
First order kinetics
194
Zero order kinetics involve _______ per unit time
Amount
195
First order kinetics involve _______ per unit time
Fractions
196
Mathematical modeling of elimination: Rate is constant and independent of drug
Zero order kinetics
197
Mathematical modeling of elimination: Rate is diminishing and always in proportion to the amount of drug in the body
First order kinetics
198
Pattern of half-life in zero order kinetics
Dependent on starting drug concentration Each subsequent half-life is half of the preceding one
199
Pattern of half-life in first order kinetics
Constant regardless of drug concentration
200
Loading and maintenance doses must be corrected for _________ less than 1.0
Bioavailabilities (F)
201
Loading and maintenance doses must be corrected for bioavailabilities (F) less than this
1.0
202
Once a steady state has been achieved, this can be used to sustain it over time
Maintenance dose
203
For maintenance dose, use this as the dosing interval
Drug's half life
204
Maximal blood level is _____ the drug serum concentration achieved with the first dose
Twice
205
Minimal blood level is _______ the drug serum concentration achieved with the first dose
Equal
206
Loading dose is ______ the maintenance dose
Twice
207
Loading dose is twice this
Maintenance dose
208
Refers to the condition where overall drug intake is in dynamic equilibrium with its elimination, and is generally achieved within five half-lives (for first order kinetics)
Steady state concentration (Css)
209
Equation for steady state concentration (Css)
Css = Rate in (infusion rate) / Rate out (elimination/clearance)